Hydra Biosciences Private
Hydra Biosciences develops novel drugs to treat pain, inflammation, cardiovascular and other diseases using ion channels.
Founded Date:
2001
Industry:
PharmTech
Estimated Revenue:
$1M to $10M
Headquarters:
Cambridge, Massachusetts, United States
Technology:
Cancer
Employee Number:
11-50
Funding Status:
Late Stage Venture